drug · small molecule
AZ-002
Phase 3updated 3mo agoby UCB SA🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 3Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 7 investigational indications.
targets
GABA-A receptor; anion channel
all catalysts(0)
nothing on the calendar yet
Trials studying AZ-002
- phase3A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
- phase3A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
- phase1Staccato Alprazolam Abuse Liability
- phase2Staccato Alprazolam and Photoparoxysmal Response
- phase1A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants
- phase1A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience
- phase1A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users
- phase1Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that